1. Febuxostat in Hyperuricemic Patients With Advanced CKD
Doo-Ho Lim, MD, Ji Seon Oh, MD, PhD, Soo Min Ahn, MD, Seokchan Hong, MD, PhD, Yong-Gil Kim, MD, PhD, Chang-Keun Lee, MD, PhD, Seung Won Choi, MD, PhD, Bin Yoo, MD, PhD 
American Journal of Kidney Diseases 
Volume 68, Issue 5, Pages (November 2016)
DOI: /j.ajkd
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions

2. Figure 1
Changes in serum uric acid levels during the 12-month period after febuxostat initiation (number in parentheses indicates number of patients). Data are shown as mean ± SD. ∗P<0.05 versus month 0 (paired t test).
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2016 National Kidney Foundation, Inc. Terms and Conditions